Haemonetics Corporation, a healthcare company, provides products to customers involved in the processing, handling and analysis of blood. The company offers a portfolio of integrated devices and information management tools for blood and plasma collectors, hospitals, and patients worldwide. It develops and markets a range of devices and solutions to serve its customers. The company provides plasma collection systems and software, which enable plasma fractionators to make life saving pharmaceuticals. It provides analytical devices for measuring hemostasis, which enable healthcare providers to manage their patients’ bleeding risk. It makes blood processing systems and software that track life giving blood components. Finally, the company supplies systems and software, which facilitate blood transfusions and cell processing. Product Lines The company serves three customer segments, such as manufacturers of plasma derived pharmaceuticals, blood collectors, and hospitals. The company operates under four global product categories: Plasma, Blood Center, Hospital, and Software Solutions. Plasma includes plasma collection devices and disposables. Blood Center includes blood collection and processing devices and disposables. Hospital includes surgical blood salvage and blood demand diagnostic devices and disposables. Software Solutions includes information technology platforms and consulting services provided to all three markets. Although the company addresses its customers' needs through multiple product lines, the company manages its business as five segments based primarily on geography, such as North America Plasma; North America Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. Plasma The Plasma Collection Market for Fractionation — The company manufactures and markets automated plasma collection devices and respective disposables. Plasma Products: The company’s portfolio of products and services is designed to support multiple facets of plasma collector operations. With its PCS brand automated plasma collection technology, more plasma could be collected during any one donation event because the other blood components are returned to the donor through the sterile disposable sets used for the plasma donation procedure. The company offers ‘one stop shopping’ to its plasma collection customers, enabling them to source from the company the range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, such as saline. It also offers a portfolio of integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain. The company’s products automate the donor interview and qualification process; streamline the workflow process in the plasma center; provide the controls necessary to evaluate donor suitability; determine the ability to release units collected; and manage unit distribution. Blood Center The company offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The company markets the MCS (Multicomponent Collection System) brand apheresis equipment, which is designed to collect specific blood components integrated from the donor. Utilizing the MCS automated platelet collection protocols, blood centers collect one or more therapeutic ‘doses’ of platelets during a single donation. The MCS two-unit protocol or double red cell collection device helps blood collectors optimize the collection of red cells by automating the blood separation function, eliminating the need for laboratory processing, and enabling the collection of two units of red cells from a single donor thus improving the amount of red cells collected per eligible donor and helping to mitigate red cell shortages in countries where this problem exists. Blood collectors could also use the MCS system to collect one unit of red cells and a ‘jumbo’ (double) unit of plasma, or one unit of red cells and one unit of platelets from a single donor. The company also o
(HAE:New York Consolidated)
400 Wood Road
Braintree, MA 02184
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for HAE.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact HAEMONETICS CORP/MASS, please visit www.haemonetics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.